Navigation Links
Bioniche Reports Fiscal 2008 Third Quarter
Date:5/9/2008

-------------------------------------------

38,889,285 41,526,774

-------------------------------------------------------------------------

-------------------------------------------------------------------------

LIABILITIES AND SHAREHOLDERS' EQUITY

Current

Revolving credit facility 4,120,711 895,619

Accounts payable and accrued liabilities 7,856,646 6,399,382

Income and other taxes payable 445,024 283,845

Deferred government incentives 615,864 541,282

Current portion of long-term debt and

obligations under capital leases 422,507 123,769

-------------------------------------------------------------------------

13,460,752 8,243,897

-------------------------------------------------------------------------

Long-term

Long-term debt 1,838,938 421,396

Obligations under capital leases 942,924 764,933

Deferred government incentives 2,986,572 2,986,572

-------------------------------------------------------------------------

19,229,186 12,416,798

-------------------------------------------------------------------------

Shareholders' equity

Share capital 92,759,917 90,038,524

Special warrants 2,174,008 2,174,008

Other paid-in capital 5,894,348 5,528,059

Deficit (81,168,174) (68,630,615)

-------------------------------------------------------------------------

19,660,099
'/>"/>

SOURCE Bioniche Life Sciences Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

Related medicine news :

1. Bioniche Appoints U.S. President of Food Safety
2. Bioniche Reports the Passing of its Board Chair
3. Bioniche Converts a Portion of its Debt to Equity
4. Bioniche Receives Fast Track Designation For First-Line Bladder Cancer Therapy
5. Bioniche Pharma Chooses TrackWise for its Deviation Control Solution
6. Bioniche Provides Update on Refractory Bladder Cancer Trial with Urocidin(TM)
7. Bioniche Reports Fiscal 2008 Second Quarter
8. USDA Agrees to Grant Conditional License to Bioniche for its E. coli O157:H7 Cattle Vaccine
9. Bioniche Amends Terms of Convertible Debt with Laurus Master Funds
10. Bioniche Receives $5 Million of Federal Government Support to Scale-up Vaccine Production in Ontario
11. Bioniche Reports Fiscal 2008 First Quarter
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/11/2008)...cientists funded by the Biotechnology and Biologic...fast and effective way to investigate important as...of Oxford and The Open University, Dr Lynne Cox an...it flies that means flies can now be used to study...shed today in the journal Aging Cell, the research...
(Date:5/11/2008)... PITTSBURGH, May 11 /PRNewswire/ -- The winners of...re(R) are as follows:, 1st Place Overall Winner...5:14 Female: Kelly Knickelbein, Pittsburgh, ... Eric Burnett, 16:02 Female: Anna Beck, Wash... Male: Charlie Ban, Pittsburgh, Pa., 16:13 ...
(Date:5/11/2008)... WASHINGTON, May 11 /PRNewswire-USNewswire/ -- Tod...ent of American Red Cross relief supplies,touched ...clone Nargis.,This newly arrived shipment includes...squito nets to help prevent the spread of malaria....o are exposed to the,elements and vulnerable to di...
(Date:5/11/2008)...redients can be bought over the counter and safely...Day News) -- When you,re doing your spring cleanin...s a cheap and easy way for people with spring alle...al drip to get relief, says Dr. Melissa Pynnonen, ...sistant professor in the University of Michigan,s ...
Breaking Medicine News(10 mins):Health News:Human aging gene found in flies 2Health News:16th Annual Komen Pittsburgh Race for the Cure(R) Winners Announced 2Health News:Relief Supplies from American Red Cross Arrive in Myanmar 2Health News:Nasal Irrigation Can Help Fight Spring Allergies 2
...d a wonderland for smokers as they could have thei...ut any inhibition. // Sad news alas for these happ...out imposing a smoking ban in entertainment venues...smoking bans already exist in air-conditioned rest...
...aking short breaks can go a long way in making it ...nducted by Massachusetts Institute researchers. //...ing at the Massachusetts Institute of Technology i...replay' their experiences in reverse when the anim...
...coming under the microscope. Coughing up for healt...g sum and while they struggled // to make the amo...ivolous operations like a sex change, penile impla...ople’s fancy. Auditor Brian Sonntag, found many ...
...begin stem cell research in the state with the app... But the legal challenges have impeded the initiat...spring 2007 before the project will be initiated. ...nstitute for Regenerative Medicine, told his board...
Other Medicine News:Health News:Smoking Ban To Be Soon Implemented In South East Asian Bars 2Health News:Task Learning Made Simple By Taking Short Breaks 2Health News:Misplaced Priorities in Medicaid Dispensation 2Health News:Momentum of Stem cell research impeded by legal challenges 2
(Date:5/9/2008)...ologists will play key role in national effort pro...ervation Education Specialist, Pennsylvania Game ...wing article are available from the,Game Commissio...king on "Release,#049-08.", HARRISBURG, Pa., Ma...me,Commission has found itself on a new frontier: ...
(Date:5/9/2008)...a., May 9 /PRNewswire-USNewswire/ -- Many strong a...s. These can include nausea and,vomiting with shor...use.,Such symptoms can lead patients to discontinu...in management for physicians. The novel investigat...al analgesic, provided pain,relief for patients wi...
(Date:5/9/2008)..., May 9 /- Ardea Bioscience... discovery and development of,small- molecule ther...ammatory diseases, including gout, today announced...President, Finance and Operations and Chief,Financ... from our board of,directors shortly thereafter. T...
(Date:5/8/2008)...argest Renal Research Network Completes 13 Phase-I...ls in Late Stage Development, EL SEGUNDO, Calif.,...,(DCR), a Phase I-IV clinical trial research servi... device research and development for FDA approval,...n 2007 and has another 34,active trials in late st...
Breaking Medicine Technology:White Nose Syndrome: Is Pennsylvania Next? 2White Nose Syndrome: Is Pennsylvania Next? 3White Nose Syndrome: Is Pennsylvania Next? 4White Nose Syndrome: Is Pennsylvania Next? 5White Nose Syndrome: Is Pennsylvania Next? 6New Study Suggests Tapentadol IR for Acute Pain Is Associated With Improved Gastrointestinal Tolerability Compared to Oxycodone IR 2New Study Suggests Tapentadol IR for Acute Pain Is Associated With Improved Gastrointestinal Tolerability Compared to Oxycodone IR 3New Study Suggests Tapentadol IR for Acute Pain Is Associated With Improved Gastrointestinal Tolerability Compared to Oxycodone IR 4Ardea Biosciences Appoints John W. Beck Chief Financial Officer, Announces Clinical Development Progress and Reports First Quarter 2008 Financial Results 2Ardea Biosciences Appoints John W. Beck Chief Financial Officer, Announces Clinical Development Progress and Reports First Quarter 2008 Financial Results 3Ardea Biosciences Appoints John W. Beck Chief Financial Officer, Announces Clinical Development Progress and Reports First Quarter 2008 Financial Results 4Ardea Biosciences Appoints John W. Beck Chief Financial Officer, Announces Clinical Development Progress and Reports First Quarter 2008 Financial Results 5Ardea Biosciences Appoints John W. Beck Chief Financial Officer, Announces Clinical Development Progress and Reports First Quarter 2008 Financial Results 6DaVita Clinical Research Completes Record Number of Renal Trials in 2007 2Natural secretion marks difference between mole and melanoma 11317 1Natural secretion marks difference between mole and melanoma 11317 2Natural secretion marks difference between mole and melanoma 11317 3Scientists rebuild ancient proteins to reveal primordial Earths temperature 2151 1Scientists rebuild ancient proteins to reveal primordial Earths temperature 2151 2Madagascars tortoises are crawling toward extinction groups say 2149 1Madagascars tortoises are crawling toward extinction groups say 2149 2Bone complications due to cystic fibrosis have a genetic cause according to an MUHC study 11315 1
...oth Efficacy and Safety, LEXINGTON, Mass., June 07...ticals, Inc. today announced final results from,it...osterone,undecanoate), a long- acting injectable t...tment of male hypogonadism which the,Company licen...ta,from the recently completed 48-week trial showe...
...Newswire-FirstCall/ -,Neurochem (International) Li...urochem Inc. , announces that the New England,Jour...e "Eprodisate,For AA Amyloidosis Trial" (EFAAT), r...ch for a treatment of AA amyloidosis. The,results ...(KIACTA(TM)) demonstrate that this product candida...
Other Medicine Technology:Indevus Reports Positive Data From Phase III NEBIDO Trial 2Indevus Reports Positive Data From Phase III NEBIDO Trial 3Indevus Reports Positive Data From Phase III NEBIDO Trial 4Indevus Reports Positive Data From Phase III NEBIDO Trial 5Indevus Reports Positive Data From Phase III NEBIDO Trial 6Landmark Study Published in the New England Journal of Medicine,Shows Important Benefits of Eprodisate (KIACTA) Treatment for,Patients with Amyloid A (AA) Amyloidosis 2Landmark Study Published in the New England Journal of Medicine,Shows Important Benefits of Eprodisate (KIACTA) Treatment for,Patients with Amyloid A (AA) Amyloidosis 3Landmark Study Published in the New England Journal of Medicine,Shows Important Benefits of Eprodisate (KIACTA) Treatment for,Patients with Amyloid A (AA) Amyloidosis 4Landmark Study Published in the New England Journal of Medicine,Shows Important Benefits of Eprodisate (KIACTA) Treatment for,Patients with Amyloid A (AA) Amyloidosis 5
...ratory and a worldwide leader in innovative labora...nsive test menu of highly complex and unique medic... by the University of Utah, ARUP Laboratories' cli...sity teaching hospitals and children's hospitals, ...
...ratory and a worldwide leader in innovative labora...nsive test menu of highly complex and unique medic... by the University of Utah, ARUP Laboratories' cli...sity teaching hospitals and children's hospitals, ...
...ratory and a worldwide leader in innovative labora...nsive test menu of highly complex and unique medic... by the University of Utah, ARUP Laboratories' cli...sity teaching hospitals and children's hospitals, ...
...ratory and a worldwide leader in innovative labora...nsive test menu of highly complex and unique medic... by the University of Utah, ARUP Laboratories' cli...sity teaching hospitals and children's hospitals, ...
Medicine Products: